News & Updates

WellDoc®’s Digital Health and Diabetes Thought Leadership Team to Present at Upcoming Industry Conferences

March 21, 2017

Columbia, Maryland, March 21, 2017 – Digital health technology leader, WellDoc®,  announced today its involvement in several key conferences and industry events over  the next few months with various company thought leaders set to speak and/or  participate in panel discussions. The list of events is as follows:

2017 BioHealth Capital Region Forum
April 19 – 20, 2017, MedImmune, Gaithersburg, MD
WellDoc CEO Kevin McRaith will participate in the “Advancing Science” panel at 10:50 a.m. ET on April 20

Academy of Managed Care Pharmacists (AMCP) Annual Meeting 2017
March 27 – 30, 2017, Colorado Convention Center, Denver, CO
WellDoc Vice President of Clinical Advocacy Malinda Peeples, RN, MS,  CDE, will present “The Basics of Mobile Health (mHealth) and its Potential Impact” at 8:30 a.m. MT on March 30

Mid-Atlantic Telehealth Resource Center 2017 Telehealth Summit
April 2 – 4, 2017, Lansdowne Resort, Leesburg, VA
Ms. Peeples will participate in the panel discussion, “Digital Health: Innovations in Population Health and Health Service Delivery,” at 2:15 p.m. ET on April 3

American Telemedicine Association (ATA) 2017: Telehealth 2.0
April 23 – 25, 2017, Orange County Convention Center, Orlando, FL
Ms. Peeples will present with the Senior Business Lead at Ontario Telemedicine Network (OTN) on “Developing a Clinical Model for Mobile Health Integration in Ontario,” at 3:00 p.m. ET on April 23

5th Annual Medical Informatics World Conference
May 22 – 23, 2017, Renaissance Waterfront Hotel, Boston, MA
Ms. Peeples will present “Digital Health: Connecting Patients and the Healthcare Team to Deliver Clinical Outcomes” at 11:50 a.m. ET on May 23

About WellDoc®

WellDoc is a digital health technology company that develops mobile solutions to drive behavioral and clinical change in chronic disease. WellDoc’s goal is to improve patient self-management and help physicians overcome gaps in the delivery system to improve clinical outcomes and decrease cost. WellDoc has commercialized BlueStar®, a digital therapeutic, for adults with type 2 diabetes. This therapeutic is designed to fill the support gap between patients and providers during the 8700 hours that individuals live their lives outside the healthcare system each year. WellDoc has a proven track record of contributing published, peer-reviewed clinical evidence since 2008 and presented real-world patient engagement and clinical outcomes at the American Diabetes  Association’s (ADA) 76th Scientific Sessions. BlueStar® is recognized by the ADA on its website as the first and only in the new class of diabetes treatment known as Mobile Prescription Therapy. In a recently published Forbes blog, WellDoc was named among one of five healthcare tech companies to watch in 2016. For more information, visit www.WellDoc.com and www.BlueStarDiabetes.com.